UK markets closed

Abbott Laboratories (0Q15.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
109.43+1.77 (+1.64%)
At close: 06:27PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 3-0.09%
S&P500 52-week change 322.38%
52-week high 3115.80
52-week low 393.36
50-day moving average 3105.77
200-day moving average 3106.19

Share statistics

Avg vol (3-month) 383.78k
Avg vol (10-day) 3108.45k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 81.72B
% held by insiders 10.54%
% held by institutions 176.59%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.12
Trailing annual dividend yield 31.97%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 301 Jun 1998

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.96%
Operating margin (ttm)14.06%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)40.33B
Revenue per share (ttm)23.18
Quarterly revenue growth (yoy)2.20%
Gross profit (ttm)N/A
EBITDA 10.34B
Net income avi to common (ttm)5.61B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-7.10%

Balance sheet

Total cash (mrq)7.28B
Total cash per share (mrq)4.2
Total debt (mrq)15.87B
Total debt/equity (mrq)40.88%
Current ratio (mrq)N/A
Book value per share (mrq)22.26

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A